Enterocloster - OmicsDI

Show results for

Genomics (43)
Unknown (37)
Transcriptomics (5)
Metabolomics (3)
Proteomics (3)

Organisms

Mus musculus (4)
Alphavirus (3)
Betaherpesvirinae (3)
Brassica oleracea var. oleracea (3)
Cowpox virus (3)
Coxsackievirus (3)
Cytomegalovirus (3)
Dengue virus (3)
EFO:0001352 (3)
Filoviridae (3)
Hepatitis B virus (3)
Human alphaherpesvirus 1 (3)
Human betaherpesvirus 5 (3)
Human immunodeficiency virus (3)
Human immunodeficiency virus 1 (3)
Human immunodeficiency virus 2 (3)
Influenza A virus (3)
Influenza C virus (3)
Japanese encephalitis virus (3)
Japanese encephalitis virus group (3)
Lyssavirus rabies (3)
Monkeypox virus (3)
Nostoc sp. PCC 7120 = FACHB-418 (3)
Oropouche virus (3)
Orthopoxvirus (3)
Orthopoxvirus vaccinia (3)
Rattus (3)
Ruditapes decussatus (3)
Tick-borne encephalitis virus (3)
Vibrio cholerae C6706 (1)

Organisms

Enterocloster clostridioformis (5)
Enterocloster citroniae (5)
Enterocloster lavalensis (4)
Enterocloster bolteae (3)
Enterocloster aldenensis (2)
Enterocloster bolteae CAG:59 (2)
Mus musculus (2)
Enterocloster bolteae ATCC BAA-613 (1)
Enterocloster bolteae CC43_001B (1)
Enterocloster bolteae 90B8 (1)
Enterocloster bolteae 90B7 (1)
Enterocloster bolteae 90B3 (1)
Enterocloster bolteae 90A9 (1)
Enterocloster bolteae 90A5 (1)
Enterocloster bolteae WAL-14578 (1)
Enterocloster asparagiformis (1)
Enterocloster alcoholdehydrogenati (1)
Vibrio cholerae C6706 (1)

Repository

ENA (43)
geo (3)
pride (3)
biostudies-arrayexpress (2)
MetaboLights (2)
MetabolomicsWorkbench (1)

Tissue

Bacterial cells (1)
Cell culture (1)
Feces (1)

Disease

Bacterial infectious disease (1)

Technology Type

Mass Spectrometry (4)
Mass spectrometry (2)
Bottom-up proteomics (2)
ESI (1)
Shotgun proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2023 (3)
2025 (3)
2026 (2)
2024 (2)

Metabolite Name

1-O-[(3,8,9,24E)-12,15-Dihydroxy-26-oxo-3-{[(1R)-6-O-pentopyranosylhexopyranosyl]oxy}-9,19-cyclolanost-24-en-26-yl]hexopyranose (1)
1-O-[(3alpha,5xi,9xi,16alpha,18xi)-16-Hydroxy-28-oxo-3-{[4-O-(beta-D-xylopyranosyl)-beta-D-glucopyranuronosyl]oxy}olean-12-en-28-yl]-beta-D-glucopyranose (1)
1-O-((3,5.Xi.,9.Xi.)-3-((2-O-(6-Deoxy--L-mannopyranosyl)--L-arabinopyranosyl)oxy)-23-hydroxy-28-oxoolean-12-en-28-yl)-6-O--D-glucopyranosyl--D-glucopyranose (1)
4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0a,l.0l,.0aa,a]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one (1)
Respinomycin-A2 (1)
2-(2-{[2-(2-{[2-(2-{[2-(2-hydroxypropanamido)-3-methylbutanoyl]oxy}-3-methylbutanamido)-3-methylbutanoyl]oxy}propanamido)-3-methylbutanoyl]oxy}-3-methylbutanamido)-3-methylbutanoic acid (1)
Conophyllidine (1)
Vicibactin (1)
Odobromoamide (1)
(1S,2S,8,9,16,17)-1-(-D-Glucopyranosyloxy)-2,16,20-trihydroxy-9,10,14-trimethyl-11,22-dioxo-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate (1)
(2R,3S,4S,5R,6R)-6-{[1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy}-5-{[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-({[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4-diol (1)
(4E)-4-{2-[(1R,4aS,5R,6R,8aS)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}-5-oxotetrahydro-3-furanyl (2E)-4-hydroxy-2-{1-hydroxy-2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2-butenoate (1)
Afn A2 (1)
2-Ammonioethyl 1-[(9Z)-9-octadecenoyloxy]-3-(palmitoyloxy)-2-propanyl phosphate (1)
2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid (1)
(3beta,9xi)-3-{[4-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-14-hydroxybufa-4,20,22-trienolide (1)
Asperazine F (1)
Trichodepsipeptide (1)
Icosalide B (1)
Monamycin D(1) (1)
Basidiosin A (1)
Trichomide D (1)
Apicidin F (1)
Ulongamide B (1)
(2S)-N-[(2S,4S,5S)-5-{[(2,6-Dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenyl-2-hexanyl]-2-(2,4-dioxotetrahydro-1(2H)-pyrimidinyl)-3-methylbutanamide (1)
(2R,3R,4S,5S,6R)-2-{[1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy}-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol (1)
Guineamide B (1)
Destruxin-Ed1 (1)
3-(3-sec-Butyl-6-isopropyl-5,8,9-trimethyl-1,4,7,10,14,17-hexaoxoicosahydropyrrolo[1,2-d][1,4,7,10,13,16]oxapentaazacyclononadecin-16-yl)-2-methylpropanoic acid (1)
3-[(3s,6r,9r,12s,13s)-5,8,11-trihydroxy-3-(hydroxymethyl)-6-(1h-indole-3-carbonyl)-12-methyl-13-[(2r)-octan-2-yl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-9-yl]propanoic acid (1)

First Public Date

2013 (16)
2016 (7)
2024 (6)
2026 (3)
2025 (3)
2022 (2)
2019 (2)
2023 (1)
2020 (1)
2018 (1)
2014 (1)

Classification

bacteria (1)

Study type

RNA-seq of coding RNA from single cells (2)

Release Date

2025 (16)
2023 (10)
2024 (10)
2026 (2)
2021 (1)

Lab affiliation

Department of Biomedical Sciences, University of Sassari, Italy (1)
Department of Pharmacology & Therapeutics, McGill University, 3655 Prom. Sir-William-Osler, Montreal, Quebec, H3G 1Y6, Canada. (1)
Department of Pharmacology & Therapeutics, McGill University, 3655 Prom. Sir-William-Osler, Montreal, Quebec, H3G 1Y6, Canada. McGill Centre for Microbiome Research, Montreal, Quebec, Canada (1)

Tags

xref:PubMed:41446096 (1)
xref:PubMed:42526445 (1)
xref:PubMed:12747414 (1)
xref:PubMed:38530054 (1)
pathogen (1)
pathogen:bacterium (1)

Previous page
1 / 10
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 10
Next page

Sort by:

Relevance

Page size

Untargeted proteomics of Enterocloster asparagiformis, E. citroniae, E. pacaense treated with DMSO or urolithin M6

Urolithins are a class of bioactive metabolites derived from the metabolism of dietary ellagitannins by the human gut microbiota. In the gut, urolithins are dehydroxylated regioselectively based on microbiota composition and activity. A single 9-hydroxy urolithin dehydroxylase (ucd) operon in gut re...

ORGANISM(S): Enterocloster hominis (ex Hitch et al. 2024) Enterocloster citroniae Enterocloster asparagiformis Bacteria

2025-11-12 | PXD066865 | Pride

Microbiome Dmso M6 Bacteria Enterocloster Urolithin

Enterocloster aldenensis strain:25A

Enterocloster aldenensis strain:25A Genome sequencing

PRJNA1119232 | ENA

Untargeted proteomics on Enterocloster bolteae DSM 15670 Treated with urolithin C

Urolithin A is a polyphenol derived from the multi-step metabolism of dietary ellagitannins by the human gut microbiota which can affect host health. Most, but not all, individuals harbor a microbiota capable of urolithin A production; however, the enzymes that dehydroxylate its dietary precursor, u...

ORGANISM(S): Enterocloster bolteae ATCC BAA-613 Bacteria

2024-12-16 | PXD048514 | Pride

Metabolism Proteomics Bacteria Enterocloster bolteae Dsm 15670 Urolithin a Molybdopterin Urolithin c Untargeted Oxidoreductase Urolithin

Enterocloster clostridioformis strain:EC-BI

Draft Genome Sequence of Enterocloster clostridioformis Strain EC-BI Isolated from Jersey Calf Feces

PRJNA1435905 | ENA

Enterocloster citroniae strain:AHG0002

Enterocloster citroniae strain:AHG0002 Genome sequencing and assembly

PRJNA491389 | ENA

Enterocloster bolteae strain:AHG0001

Enterocloster bolteae strain:AHG0001 Genome sequencing and assembly

PRJNA491388 | ENA